Trial Profile

Randomized comparative study of ipragliflozin combination therapy and sitagliptin combination therapy in patients with type 2 diabetes administrating metformin

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Oct 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Jun 2021 Results (n=87) of post-hoc analysis of a 52-week of the NISM Study, presented at the 81st Annual Scientific Sessions of the American Diabetes Association.
16 Jun 2020 Primary endpoint (Comparison of percentage of patients who achieve the following items 52 weeks after randomization) has not been met, as per Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association
16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com